GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX21
|
ENSG00000125285.4 | SRY-box transcription factor 21 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX21 | hg19_v2_chr13_-_95364389_95364389 | -0.27 | 4.6e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_35201826 | 13.14 |
ENST00000531873.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr3_+_37035263 | 9.88 |
ENST00000458205.2
ENST00000539477.1 |
MLH1
|
mutL homolog 1 |
chr3_+_37035289 | 9.47 |
ENST00000455445.2
ENST00000441265.1 ENST00000435176.1 ENST00000429117.1 ENST00000536378.1 |
MLH1
|
mutL homolog 1 |
chr7_-_86849883 | 8.55 |
ENST00000433078.1
|
TMEM243
|
transmembrane protein 243, mitochondrial |
chr18_-_47018869 | 7.90 |
ENST00000583036.1
ENST00000580261.1 |
RPL17
|
ribosomal protein L17 |
chr19_+_42381337 | 7.85 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr19_+_42381173 | 7.84 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr3_+_37034823 | 7.67 |
ENST00000231790.2
ENST00000456676.2 |
MLH1
|
mutL homolog 1 |
chr18_-_47018897 | 7.53 |
ENST00000418495.1
|
RPL17
|
ribosomal protein L17 |
chr18_-_47018769 | 7.18 |
ENST00000583637.1
ENST00000578528.1 ENST00000578532.1 ENST00000580387.1 ENST00000579248.1 ENST00000581373.1 |
RPL17
|
ribosomal protein L17 |
chr4_-_103746683 | 6.53 |
ENST00000504211.1
ENST00000508476.1 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr4_-_103747011 | 6.26 |
ENST00000350435.7
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr7_+_2394445 | 6.23 |
ENST00000360876.4
ENST00000413917.1 ENST00000397011.2 |
EIF3B
|
eukaryotic translation initiation factor 3, subunit B |
chr4_-_103746924 | 6.04 |
ENST00000505207.1
ENST00000502404.1 ENST00000507845.1 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr14_-_107170409 | 5.79 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr12_+_69742121 | 5.78 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr5_-_95158644 | 5.54 |
ENST00000237858.6
|
GLRX
|
glutaredoxin (thioltransferase) |
chr3_-_141747439 | 5.54 |
ENST00000467667.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr15_-_80263506 | 4.90 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr6_+_31371337 | 4.58 |
ENST00000449934.2
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
chr9_-_70465758 | 3.98 |
ENST00000489273.1
|
CBWD5
|
COBW domain containing 5 |
chr8_+_26150628 | 3.97 |
ENST00000523925.1
ENST00000315985.7 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr3_-_141747459 | 3.87 |
ENST00000477292.1
ENST00000478006.1 ENST00000495310.1 ENST00000486111.1 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr5_-_95158375 | 3.86 |
ENST00000512469.2
ENST00000379979.4 ENST00000505427.1 ENST00000508780.1 |
GLRX
|
glutaredoxin (thioltransferase) |
chr12_-_89746173 | 3.30 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
chr10_-_12084770 | 3.00 |
ENST00000357604.5
|
UPF2
|
UPF2 regulator of nonsense transcripts homolog (yeast) |
chr5_-_179045199 | 2.83 |
ENST00000523921.1
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H) |
chr1_+_203764742 | 2.73 |
ENST00000432282.1
ENST00000453771.1 ENST00000367214.1 ENST00000367212.3 ENST00000332127.4 |
ZC3H11A
|
zinc finger CCCH-type containing 11A |
chr12_+_123011776 | 2.41 |
ENST00000450485.2
ENST00000333479.7 |
KNTC1
|
kinetochore associated 1 |
chr16_-_15149828 | 2.33 |
ENST00000566419.1
ENST00000568320.1 |
NTAN1
|
N-terminal asparagine amidase |
chr17_+_66245341 | 2.23 |
ENST00000577985.1
|
AMZ2
|
archaelysin family metallopeptidase 2 |
chr19_+_18682531 | 2.20 |
ENST00000596304.1
ENST00000430157.2 |
UBA52
|
ubiquitin A-52 residue ribosomal protein fusion product 1 |
chr22_+_23063100 | 2.08 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr6_+_42531798 | 2.02 |
ENST00000372903.2
ENST00000372899.1 ENST00000372901.1 |
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2 |
chr22_+_39353527 | 1.97 |
ENST00000249116.2
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A |
chr1_+_221051699 | 1.97 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
chr20_+_43343886 | 1.68 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr3_+_57994127 | 1.54 |
ENST00000490882.1
ENST00000295956.4 ENST00000358537.3 ENST00000429972.2 ENST00000348383.5 ENST00000357272.4 |
FLNB
|
filamin B, beta |
chr1_+_146714291 | 1.52 |
ENST00000431239.1
ENST00000369259.3 ENST00000369258.4 ENST00000361293.5 |
CHD1L
|
chromodomain helicase DNA binding protein 1-like |
chr4_+_69313145 | 1.35 |
ENST00000305363.4
|
TMPRSS11E
|
transmembrane protease, serine 11E |
chr12_-_7261772 | 1.18 |
ENST00000545280.1
ENST00000543933.1 ENST00000545337.1 ENST00000544702.1 ENST00000266542.4 |
C1RL
|
complement component 1, r subcomponent-like |
chr1_-_54303934 | 0.98 |
ENST00000537333.1
|
NDC1
|
NDC1 transmembrane nucleoporin |
chr6_-_112575912 | 0.96 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr8_-_143961236 | 0.92 |
ENST00000377675.3
ENST00000517471.1 ENST00000292427.4 |
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1 |
chr19_-_54784937 | 0.92 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr20_+_56964253 | 0.91 |
ENST00000395802.3
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C |
chr2_+_217363559 | 0.90 |
ENST00000600880.1
ENST00000446558.1 |
RPL37A
|
ribosomal protein L37a |
chr3_-_155524049 | 0.87 |
ENST00000534941.1
ENST00000340171.2 |
C3orf33
|
chromosome 3 open reading frame 33 |
chr2_+_3705785 | 0.85 |
ENST00000252505.3
|
ALLC
|
allantoicase |
chr1_+_199996733 | 0.79 |
ENST00000236914.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr6_-_112575758 | 0.77 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
chr14_-_102771462 | 0.73 |
ENST00000522874.1
|
MOK
|
MOK protein kinase |
chr14_-_92588246 | 0.57 |
ENST00000329559.3
|
NDUFB1
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
chr3_-_155572164 | 0.47 |
ENST00000392845.3
ENST00000359479.3 |
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1 |
chr11_-_8285405 | 0.45 |
ENST00000335790.3
ENST00000534484.1 |
LMO1
|
LIM domain only 1 (rhombotin 1) |
chr10_-_17243579 | 0.41 |
ENST00000525762.1
ENST00000412821.3 ENST00000351358.4 ENST00000377766.5 ENST00000358282.7 ENST00000488990.1 ENST00000377799.3 |
TRDMT1
|
tRNA aspartic acid methyltransferase 1 |
chr14_-_92588013 | 0.40 |
ENST00000553514.1
ENST00000605997.1 |
NDUFB1
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
chr12_+_20522179 | 0.37 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr12_-_10324716 | 0.36 |
ENST00000545927.1
ENST00000432556.2 ENST00000309539.3 ENST00000544577.1 |
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1 |
chr1_-_217250231 | 0.22 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
chr4_+_81951957 | 0.18 |
ENST00000282701.2
|
BMP3
|
bone morphogenetic protein 3 |
chr11_+_114168085 | 0.14 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr22_-_40929812 | 0.14 |
ENST00000422851.1
|
MKL1
|
megakaryoblastic leukemia (translocation) 1 |
chr1_-_169455169 | 0.14 |
ENST00000367804.4
ENST00000236137.5 |
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2 |
chr8_-_142377367 | 0.12 |
ENST00000377741.3
|
GPR20
|
G protein-coupled receptor 20 |
chr6_-_112575838 | 0.10 |
ENST00000455073.1
|
LAMA4
|
laminin, alpha 4 |
chrY_+_14813160 | 0.07 |
ENST00000338981.3
|
USP9Y
|
ubiquitin specific peptidase 9, Y-linked |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 27.0 | GO:0051311 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
1.6 | 13.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.2 | 5.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
1.1 | 4.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.8 | 3.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.8 | 6.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 9.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 18.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 2.0 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.3 | 2.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 2.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 1.0 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.3 | 0.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.2 | 9.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 4.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 4.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 25.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.2 | 0.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 2.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 15.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 2.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 1.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.9 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 9.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.5 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
0.0 | 3.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.0 | 2.3 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.0 | 2.8 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.4 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 1.8 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 27.0 | GO:0005715 | late recombination nodule(GO:0005715) |
2.2 | 15.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.9 | 13.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.7 | 6.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 2.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 1.0 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.2 | 25.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 2.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 4.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 3.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 5.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 10.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 1.8 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 18.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 2.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 4.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 1.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 1.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 27.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.0 | 5.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.9 | 9.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 4.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 13.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 18.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 0.9 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.3 | 0.9 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 4.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 4.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 6.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 2.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.9 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.1 | 25.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.1 | 3.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.0 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 10.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.0 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 2.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 10.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 15.6 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 18.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 13.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 20.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 27.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 9.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 5.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 4.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 13.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 21.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 27.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 15.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 6.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 9.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 30.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 5.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 2.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 2.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |